Cargando…
Immune checkpoints, their control by immunotherapy and ovarian cancer
Immune checkpoints are new targets for manipulation of immunological control over malignant tumors. They provide an important means to manage especially recurrent and refractory cancers and those cancers where there is an unmet need such as recurrent melanoma, renal cell carcinoma and recurrent ovar...
Autor principal: | Bose, Chinmoy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701579/ https://www.ncbi.nlm.nih.gov/pubmed/29180924 http://dx.doi.org/10.5114/wo.2017.70108 |
Ejemplares similares
-
Immune Checkpoint Blockers and Ovarian Cancer
por: Bose, Chinmoy K
Publicado: (2017) -
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
por: De Felice, Francesca, et al.
Publicado: (2015) -
Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015) -
Immune checkpoint signaling and cancer immunotherapy
por: He, Xing, et al.
Publicado: (2020) -
Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)